Beranda › Kanker Paru › Kansas › Kansas City
Uji klinis Kanker Paru di Kansas City, KS
11 studi untuk Kanker Paru mencari peserta di lokasi sekitar Kansas City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Veteran Administration Eastern Kansas Healthcare, Leavenworth · 21 mi jauhnya
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
Menerima pesertaFase 1/2
- University of Kansas Cancer Center, Kansas City
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Menerima pesertaFase 1
- University of Kansas Medical Center, Kansas City
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Menerima pesertaFase 3
- University of Kansas Cancer Center, Kansas City
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Menerima pesertaFase 3
- University of Kansas Cancer Center, Kansas City
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Menerima pesertaFase 1/2
- The University of Kansas Cancer Center, Kansas City
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- University of Kansas Cancer Center, Kansas City
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2/3
- University of Kansas Cancer Center, Kansas City
- Veteran Administration Eastern Kansas Healthcare, Leavenworth · 21 mi jauhnya
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- University of Kansas Cancer Center, Kansas City
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
Menerima pesertaStudi observasional
- University of Kansas Medical Center, Kansas City
Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC
Menerima pesertaStudi observasional
- The University of Kansas Cancer Center, Westwood Campus, Kansas City
Uji klinis Kanker Paru di kota lain
- Houston, TX78 studi
- Boston, MA62 studi
- New York City, NY60 studi
- Los Angeles, CA45 studi
- Arlington, VA41 studi
- Washington, DC41 studi
- Chicago, IL41 studi
- Nashville, TN40 studi
- Baltimore, MD40 studi
- St. Louis, MO39 studi
- Columbus, OH37 studi
- Philadelphia, PA36 studi
Studi lain di Kansas City
- Penyakit Kardiovaskular14 studi
- Gagal Jantung13 studi
- Obesitas13 studi
- Penyakit Paru Interstisial13 studi
- Fibrosis Kistik13 studi
- Kanker Payudara12 studi
- Kanker Kandung Kemih12 studi
- Leukemia Mieloid Akut12 studi
- Kanker Prostat12 studi
- Kanker Paru Non-Sel Kecil11 studi
- PPOK9 studi
- Asma8 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.